Erratum to “Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)” [Atherosclerosis 200 (2008) 135–140]

2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia

Virani, S. S., Morris, P. B., Agarwala, A., Ballantyne, C. M., Birtcher, K. K., Kris-Etherton, P. M., Ladden-Stirling, A. B., Miller, M., Orringer, C. E., & Stone, N. J. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.06.011 · Cited by 341 · see citing works

Health benefits of marine foods and ingredients

Larsen, R., Eilertsen, K., & Elvevoll, E. O. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.05.017 · Cited by 294 · see citing works

Rationale and design of <scp>REDUCE‐IT</scp> : Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Bhatt, D. L., Steg, P. G., Brinton, E. A., Jacobson, T. A., Miller, M., Tardif, J., Ketchum, S. B., Doyle, R. T., Murphy, S. A., Soni, P. N., et al. (2017) · Clinical Cardiology · doi:10.1002/clc.22692 · Cited by 183 · see citing works

Oxidative Stress as Pathogenesis of Cardiovascular Risk Associated with Metabolic Syndrome

Otani, H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3739 · Cited by 181 · see citing works

Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis

Borow, K. M., Nelson, J. R., & Mason, R. P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.035 · Cited by 175 · see citing works

Defective Phagocytosis of Apoptotic Cells by Macrophages in Atherosclerotic Lesions of ob/ob Mice and Reversal by a Fish Oil Diet

Li, S., Sun, Y., Liang, C., Thorp, E. B., Han, S., Jehle, A. W., Saraswathi, V., Pridgen, B. C., Kanter, J. E., Li, R., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.199570 · Cited by 167 · see citing works

4-Hydroxy Hexenal Derived from Docosahexaenoic Acid Protects Endothelial Cells via Nrf2 Activation

Ishikado, A., Morino, K., Nishio, Y., Nakagawa, F., Mukose, A., Sono, Y., Nagisa, Y., Kondo, K., Sekine, O., Yoshizaki, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069415 · Cited by 83 · see citing works

Eicosapentaenoic Acid Enhances Heat Stress-Impaired Intestinal Epithelial Barrier Function in Caco-2 Cells

Xiao, G., Tang, L., Yuan, F., Zhu, W. Z., Zhang, S., Liu, Z., Geng, Y., Qiu, X., Zhang, Y., & Su, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073571 · Cited by 82 · see citing works

Update on marine omega-3 fatty acids: Management of dyslipidemia and current omega-3 treatment options

WEINTRAUB, H. S. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.041 · Cited by 81 · see citing works

Overview of Prescription Omega-3 Fatty Acid Products for Hypertriglyceridemia

WEINTRAUB, H. S. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.11.2828 · Cited by 74 · see citing works

Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells

Ishikado, A., Nishio, Y., Morino, K., Ugi, S., KONDO, H., Makino, T., Kashiwagi, A., & Maegawa, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.124 · Cited by 74 · see citing works

Conducting omega-3 clinical trials with cardiovascular outcomes: Proceedings of a workshop held at ISSFAL 2014

Rice, H. B., Bernasconi, A. A., Maki, K. C., Harris, W. S., von Schacky, C., & Calder, P. C. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.01.003 · Cited by 56 · see citing works

Effects of Serum n-3 to n-6 Polyunsaturated Fatty Acids Ratios on Coronary Atherosclerosis in Statin-Treated Patients With Coronary Artery Disease

Nozue, T., Yamamoto, S., Tohyama, S., Fukui, K., Umezawa, S., Onishi, Y., Kunishima, T., Sato, A., Nozato, T., Miyake, S., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.08.038 · Cited by 51 · see citing works

Omega-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia

Pirillo, A., & Catapano, A. L. (2013) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(13)70004-7 · Cited by 36 · see citing works

The fatty acid oxidation product 15‐A3t‐Isoprostane is a potent inhibitor of NFκB transcription and macrophage transformation

Brooks, J. D., Musiek, E. S., Koestner, T. H., Stankowski, J. N., Howard, J. R. H., Brunoldi, E. M., Porta, A., Zanoni, G., Vidari, G., Morrow, J. D., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07422.x · Cited by 29 · see citing works

Fish oils, coronary heart disease, and the environment

Greene, J., Ashburn, S. M., Razzouk, L., & Smith, D. A. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.300959 · Cited by 23 · see citing works

Comparison of Effects of Serum n-3 to n-6 Polyunsaturated Fatty Acid Ratios on Coronary Atherosclerosis in Patients Treated With Pitavastatin or Pravastatin Undergoing Percutaneous Coronary Intervention

Nozue, T., Yamamoto, S., Tohyama, S., Fukui, K., Umezawa, S., Onishi, Y., Kunishima, T., Sato, A., Nozato, T., Miyake, S., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.327 · Cited by 23 · see citing works

Reverse association of omega-3/omega-6 polyunsaturated fatty acids ratios with carotid atherosclerosis in patients on hemodialysis

Umemoto, N., Ishii, H., Kamoi, D., Aoyama, T., Sakakibara, T., Takahashi, H., Tanaka, A., Yasuda, Y., Suzuki, S., Matsubara, T., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.037 · Cited by 23 · see citing works

Potential of combining flaxseed oil and microalgal biomass in producing eggs-enriched with n − 3 fatty acids for meeting human needs

Kim, J., Magnuson, A. D., Tao, L., Barcus, M., & Lei, X. G. (2016) · Algal Research · doi:10.1016/j.algal.2016.04.005 · Cited by 20 · see citing works

Association between the docosahexaenoic acid to arachidonic acid ratio and acute coronary syndrome: a multicenter observational study

Nishizaki, Y., Shimada, K., Tani, S., Ogawa, T., Ando, J., Takahashi, M., Yamamoto, M., Shinozaki, T., Miyazaki, T., Miyauchi, K., et al. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0299-y · Cited by 19 · see citing works

The lipid paradox in neuroprogressive disorders: Causes and consequences

Morris, G., Berk, M., Walder, K., O’Neil, A., Maes, M., & Puri, B. K. (2021) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.017 · Cited by 17 · see citing works

High long-chain n-3 fatty acid intake attenuates the effect of high resting heart rate on cardiovascular mortality risk: A 24-year follow-up of Japanese general population

Hisamatsu, T., Miura, K., Ohkubo, T., Yamamoto, T., Fujiyoshi, A., Miyagawa, N., Kadota, A., Takashima, N., Okuda, N., Yoshita, K., et al. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.01.005 · Cited by 11 · see citing works

Dietary fish oil is antihypertrophic but does not enhance postischemic myocardial function in female mice

Huggins, C. E., Curl, C. L., Patel, R., McLennan, P. L., Theiss, M. L., Pedrazzini, T., Pepe, S., & Delbridge, L. M. D. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01151.2008 · Cited by 10 · see citing works

Triglycerides and Cardiovascular Disease : A Scientific Statement From the

Pennathur, S., Kris‐Etherton, P. M., Lennie, T. A., Levi, M., Mazzone, T., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Stone, N. J., Ballantyne, C. M., et al. (2011) · Cited by 6 · see citing works

Residual cardiac risk reduction beyond lipid lowering.

Pagourelias, E. D., Gossios, T. D., Τζιόμαλος, Κ., Karagiannis, A. I., Geleris, P., & Athyros, V. G. (2011) · PubMed · Cited by 2 · see citing works

Srce i krvni Sudovi

Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)

Hypertriglyceridemia: Should We Treat?

Brinton, E. A. (2014) · The Endocrine Society eBooks · doi:10.1210/mtp3.9781936704835.ch27

Triglycerides and Cardiovascular Disease: A Scientific Statement From the American

Lennie, T. A., Levi, M., Mazzone, T., Pennathur, S., Goldberg, A. C., Howard, W. J., Jacobson, M. Z., Stone, N. J., Ballantyne, C. M., Bittner, V., et al. (2013)

NARRATIVE REVIEW Omega-3 Polyunsaturated Fatty Acids in the Treatment of Kidney Disease

Fassett, R. G., Gobe, G. C., Peake, J. M., & Coombes, J. S. (2010)

Nutrition and Coronary Heart Disease Prevention

Schaefer, E. J., & Tani, M. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_19

4 Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors : Sub-analysis of primary prevention cases from JELIS(Late Breaking Clinical Trials I,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)

Ishikawa, Y., Matsuzaki, M., Origasa, H., Matsuzawa, Y., Saitō, Y., Yokoyama, M., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2008) · Japanese Circulation Journal-english Edition

Department of Error

(2007) · The Lancet · doi:10.1016/s0140-6736(07)61123-4 · Cited by 2 · see citing works

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.003 · Cited by 316 · see citing works

Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)

Oikawa, S., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Sasaki, J., Hishida, H., Itakura, H., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.029 · Cited by 125 · see citing works

Relationship between Coronary Artery Disease and Non-HDL-C, and Effect of Highly Purified EPA on the Risk of Coronary Artery Disease in Hypercholesterolemic Patients Treated with Statins: Sub-Analysis of the Japan EPA Lipid Intervention Study (JELIS)

Sasaki, J., Yokoyama, M., Matsuzaki, M., Saito, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Itakura, H., Hishida, H., Kita, T., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.8326 · Cited by 35 · see citing works